Positive expiratory pressure for the treatment of high-altitude pulmonary oedema

Accusations that hospital staff have abused pediatric patients.

Child abuse & neglect·2002

The cause of infant and toddler subdural hemorrhage: a prospective study.

Pediatrics·2001

Intermediate-term results in pediatric aortic valve replacement.

The Annals of thoracic surgery·1999

Bruises in infants and toddlers: those who don't cruise rarely bruise. Puget Sound Pediatric Research Network.

Archives of pediatrics & adolescent medicine·1999

The central venous catheter as a source of medical chaos in Munchausen syndrome by proxy.

Journal of pediatric surgery·1998

Comparison of human tissues and mechanical prostheses for aortic valve replacement in children.

Circulation·1997

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

UV-derived scattering as a high-throughput readout for adeno-associated virus-like particle separation screenings.

Frontiers in bioengineering and biotechnology·2026

Study-Grouped Predictive Toxicology of In Vitro Polystyrene Micro- and Nanoplastic Cytotoxicity: Geometry-Derived Administered-Dose Metrics and a Nanoscale-Restricted Sensitivity Analysis.

Polymers·2026

Acid alone does not digest: a lesson from nineteenth-century stomach physiology.

Advances in physiology education·2026

The Impact of Pathogen Inactivation Technologies on Platelet Quality and Clot Formation.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie·2026

Capillary physics links HIV capsid geometry to nuclear pore translocation.

Proceedings of the National Academy of Sciences of the United States of America·2026

Identification of the Root Cause of Visible Particle Formation in a Therapeutic Monoclonal Antibody by LC-MS-Based Approaches.

Molecular pharmaceutics·2026

Related Experiment Videos

Positive expiratory pressure for the treatment of high-altitude pulmonary oedema

Related Concept Videos

Accusations that hospital staff have abused pediatric patients.

The cause of infant and toddler subdural hemorrhage: a prospective study.

Intermediate-term results in pediatric aortic valve replacement.

Bruises in infants and toddlers: those who don't cruise rarely bruise. Puget Sound Pediatric Research Network.

The central venous catheter as a source of medical chaos in Munchausen syndrome by proxy.

Comparison of human tissues and mechanical prostheses for aortic valve replacement in children.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

UV-derived scattering as a high-throughput readout for adeno-associated virus-like particle separation screenings.

Study-Grouped Predictive Toxicology of In Vitro Polystyrene Micro- and Nanoplastic Cytotoxicity: Geometry-Derived Administered-Dose Metrics and a Nanoscale-Restricted Sensitivity Analysis.

Acid alone does not digest: a lesson from nineteenth-century stomach physiology.

The Impact of Pathogen Inactivation Technologies on Platelet Quality and Clot Formation.

Capillary physics links HIV capsid geometry to nuclear pore translocation.

Identification of the Root Cause of Visible Particle Formation in a Therapeutic Monoclonal Antibody by LC-MS-Based Approaches.

Related Experiment Videos

Positive expiratory pressure for the treatment of high-altitude pulmonary oedema

Related Concept Videos

Related Articles